Financhill
Buy
55

LPTX Quote, Financials, Valuation and Earnings

Last price:
$3.43
Seasonality move :
-7.52%
Day range:
$3.35 - $3.58
52-week range:
$1.68 - $4.79
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
77.96x
P/B ratio:
2.72x
Volume:
190.6K
Avg. volume:
383.2K
1-year change:
-15.33%
Market cap:
$133.3M
Revenue:
--
EPS (TTM):
-$1.67

Earnings Data

Next earnings date for LPTX
Mar 18
2025
Most recent earnings per share
-$0.44
Beat by $0.03
(Nov 13/2024)
Consensus Estimate
-$0.47
(Nov 13/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

LPTX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2025 Q1 -- -- -- -$0.38 --
03/18/2025 Q4 -- -- -- -$0.38 --
11/13/2024 Q3 -- -- -$0.44 -$0.47 $0.03
08/12/2024 Q2 -- -- -$0.52 -$0.41 -$0.12
05/13/2024 Q1 -- -- -$0.51 -$0.59 $0.08
03/18/2024 Q4 -- -- -$0.20 -$0.56 $0.36
11/13/2023 Q3 -- -- -$0.51 -$0.58 $0.07
06/30/2023 Q2 -- -- -$0.91 -$0.89 -$0.03
03/31/2023 Q1 -- -- -$3.24 -$0.80 -$2.44
12/31/2022 Q4 -- -- -$1.10 -$1.05 -$0.05
09/30/2022 Q3 -- -- -$1.33 -- --
06/30/2022 Q2 -- -- -$1.50 -- --
03/31/2022 Q1 -- -- -$0.90 -- --
12/31/2021 Q4 -- -- -$1.00 -- --
09/30/2021 Q3 -- -- -$1.40 -- --
06/30/2021 Q2 -- -- -$1.20 -- --
03/31/2021 Q1 -- -- -$1.20 -- --
12/31/2020 Q4 -- -- -$0.90 -- --
09/30/2020 Q3 -- -- -$0.90 -- --
06/30/2020 Q2 -- -- -$1.20 -- --
03/31/2020 Q1 -- -- -$5.50 -- --
12/31/2019 Q4 -- -- -$3.30 -- --
09/30/2019 Q3 -- -- -$3.30 -- --
06/30/2019 Q2 -- -- -$3.70 -- --
03/31/2019 Q1 -- -- -$4.70 -- --
12/31/2018 Q4 -- -- -$3.50 -- --
09/30/2018 Q3 -- -- -$5.50 -- --
06/30/2018 Q2 -- -- -$5.00 -- --
03/31/2018 Q1 -- -- -$8.50 -- --
12/31/2017 Q4 -- -- -$6.50 -- --
09/30/2017 Q3 -- -- -$7.30 -- --
06/30/2017 Q2 -- -- -$7.40 -- --
03/31/2017 Q1 -- -- -$13.90 -- --
12/31/2016 Q4 -- -- -$3.36 -- --
09/30/2016 Q3 -- -- -$4.26 -- --
06/30/2016 Q2 -- -- -$4.38 -- --
03/31/2016 Q1 -- -- -$3.01 -- --
12/31/2015 Q4 -- -- $4.31 -- --
09/30/2015 Q3 -- -- -$3.20 -- --
06/30/2015 Q2 -- -- -$3.60 -- --
03/31/2015 Q1 -- -- -$3.80 -- --

Leap Therapeutics Earnings Questions

  • How Much did Leap Therapeutics Generate in Revenue Last Quarter?

    Leap Therapeutics reported -- worth of top line sales in its most recent quarter.

  • Did Leap Therapeutics Beat Earnings Last Quarter?

    Leap Therapeutics announced earnings per share of -$0.44 which represents a beat of analyst forecast a -$0.47 per share.

  • Is Leap Therapeutics Profitable?

    Leap Therapeutics reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Leap Therapeutics EPS Next Year?

    Leap Therapeutics's earnings are forecast to decrease from -$3.98 per share to -$1.83 per share next year representing a decrease of -54.02%.

  • When is Leap Therapeutics's Earnings Date?

    Leap Therapeutics's next earnings date is March 18, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is SCHD a Good ETF to Buy?
Is SCHD a Good ETF to Buy?

With around $65.7 billion in net assets, Schwab’s US Dividend…

Is NAIL a Good ETF to Buy?
Is NAIL a Good ETF to Buy?

If you’re thinking about buying the NAIL ETF, this article…

3 High Dividend Dow Jones Stocks
3 High Dividend Dow Jones Stocks

Thanks to surging stock prices over the past two years,…

Stock Ideas

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 40x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 117x

Sell
43
Is MSFT Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 36x

Alerts

Buy
57
NARI alert for Jan 8

Inari Medical [NARI] is up 22.25% over the past day.

Buy
69
UNF alert for Jan 8

UniFirst [UNF] is up 20.59% over the past day.

Sell
31
APOG alert for Jan 8

Apogee Enterprises [APOG] is down 19.13% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock